HSPA5 and colorectal cancer: Similarly, La et al. demonstrated that 50 μM of epigallocatechin gallate (EGCG) sensitized DLD1 colorectal cancer cells to 5-fluorouracil by modulating GRP78, NF-κB, miR-155-5p, and MDR1 pathways [34].